مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

293
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

128
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

A COMPARISON BETWEEN HYBRID AND CONCOMITANT REGIMENS FOR HELICOBACTER PYLORI ERADICATION: A RANDOMIZED CLINICAL TRIAL

Pages

  241-247

Keywords

Not Registered.

Abstract

 BACKGROUND: Helicobacter pylori (H. pylori)is one of the most common bacterial infections worldwide. We designed a study to compare the efficacy of 14-day hybrid regimen with 10-day concomitant therapy forH. pylori eradication in Iran.METHODS 252 patients with naïveH. pylori infection were randomly divided to receive either hybrid regimen (pantoprazole 40 mg, and amoxicillin 1 gr twice daily for 14 days, accompanied by clarithromycin 500 mg, and metronidazole 500 mg, twice daily just during the last 7 days) or concomitant regimen (pantoprazole 40 mg, amoxicillin 1 gr, clarithromycin 500 mg, and metronidazole 500 mg, all twice daily for 10 days).8 weeks after therapy, 14C- urease breath test was performed to confirm eradication.RESULTS: According to intention to treat analysis, the eradication rates were 87.3% (95% CI: 81.4–93.1) and 80.9% (95% CI: 74-87.8) in hybrid and concomitant groups, respectively (p=0.38). Per-protocol eradication rates were 89.3% (95% CI: 83.8-94.7) and 83.1% (95% CI: 76.3-89.8), respectively (p=0.19). The rates of severe side effects were not statistically different between the two groups (4% vs.8.7%).CONCLUSION: 14-day hybrid therapy can be considered as a nearly acceptable regimen with few severe side effects in Iran. However, it seems that the efficacy of this therapy is decreasing as the resistance rates to antibiotics are increasing. We suggest further studies to assess the efficacy of a more prolonged concomitant therapy forH. pylori eradication in Iran.

Cites

  • No record.
  • References

    Cite

    APA: Copy

    ALHOOEI, SAMAN, TIRGAR FAKHERI, HAFEZ, HOSSEINI, VAHID, MALEKI, IRADJ, TAGHVAEI, TARANG, VALIZADEH, SEYED MOHAMMAD, & BARI, ZOHRE. (2016). A COMPARISON BETWEEN HYBRID AND CONCOMITANT REGIMENS FOR HELICOBACTER PYLORI ERADICATION: A RANDOMIZED CLINICAL TRIAL. MIDDLE EAST JOURNAL OF DIGESTIVE DISEASES (MEJDD), 8(3), 241-247. SID. https://sid.ir/paper/319140/en

    Vancouver: Copy

    ALHOOEI SAMAN, TIRGAR FAKHERI HAFEZ, HOSSEINI VAHID, MALEKI IRADJ, TAGHVAEI TARANG, VALIZADEH SEYED MOHAMMAD, BARI ZOHRE. A COMPARISON BETWEEN HYBRID AND CONCOMITANT REGIMENS FOR HELICOBACTER PYLORI ERADICATION: A RANDOMIZED CLINICAL TRIAL. MIDDLE EAST JOURNAL OF DIGESTIVE DISEASES (MEJDD)[Internet]. 2016;8(3):241-247. Available from: https://sid.ir/paper/319140/en

    IEEE: Copy

    SAMAN ALHOOEI, HAFEZ TIRGAR FAKHERI, VAHID HOSSEINI, IRADJ MALEKI, TARANG TAGHVAEI, SEYED MOHAMMAD VALIZADEH, and ZOHRE BARI, “A COMPARISON BETWEEN HYBRID AND CONCOMITANT REGIMENS FOR HELICOBACTER PYLORI ERADICATION: A RANDOMIZED CLINICAL TRIAL,” MIDDLE EAST JOURNAL OF DIGESTIVE DISEASES (MEJDD), vol. 8, no. 3, pp. 241–247, 2016, [Online]. Available: https://sid.ir/paper/319140/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button